Table 3.
CpG probe | Chr | Position (bps) | Genomic features | p-value | q-value | Gene* | Direction† |
---|---|---|---|---|---|---|---|
cg21406811 | 1 | 51,271,043 | introns | 4.08×10−12 | 1.63×10−6 | FAF1 | ↑ |
cg23067228 | 15 | 70,881,206 | intergenic | 7.37×10−12 | 1.63×10−6 | ↑ | |
cg22895202 | 14 | 21,238,166 | promoters | 3.11×10−11 | 4.58×10−6 | EDDM3B | ↑ |
cg09183598 | 19 | 57,679,015 | promoters | 5.26×10−11 | 5.81×10−6 | DUXA | ↑ |
cg12308275 | 15 | 43,558,855 | promoters | 1.54×10−10 | 1.37×10−5 | TGM5 | ↑ |
cg16008918 | 4 | 78,740,080 | intergenic | 2.03×10−10 | 1.49×10−5 | ↑ | |
cg13689497 | 19 | 3,201,528 | intergenic | 2.82×10−9 | 1.78×10−4 | ↑ | |
cg17678740 | 7 | 53,254,947 | intergenic | 4.36×10−9 | 2.41×10−4 | ↓ | |
cg23524184 | 17 | 48,129,754 | intergenic | 2.75×10−8 | 1.25×10−3 | ITGA3 | ↑ |
cg22661129 | 8 | 35,580,715 | promoters | 3.11×10−8 | 1.25×10−3 | UNC5D | ↑ |
cg25868285 | 7 | 134,455,275 | intergenic | 3.12×10−8 | 1.25×10−3 | ↑ | |
cg04559604 | 8 | 22,031,763 | intergenic | 5.34×10−8 | 1.97×10−3 | ↑ | |
cg01363574 | 3 | 40,354,920 | intergenic | 1.03×10−7 | 3.31×10−3 | EIF1B-AS1 | ↑ |
cg16353628 | 2 | 85,239,916 | introns | 1.05×10−7 | 3.31×10−3 | KCMF1 | ↑ |
cg09352908 | 3 | 37,017,749 | intergenic | 1.23×10−7 | 3.63×10−3 | ↓ | |
cg14115740 | 9 | 98,054,883 | intergenic | 2.16×10−7 | 5.97×10−3 | ↓ | |
cg04212651 | 6 | 112,671,523 | promoters | 2.30×10−7 | 5.98×10−3 | RFPL4B | ↑ |
cg02745683 | 4 | 3,513,990 | exons | 2.60×10−7 | 6.28×10−3 | LRPAP1 | ↑ |
cg20376421 | 12 | 56,546,193 | promoters | 2.70×10−7 | 6.28×10−3 | MYL6B | ↓ |
cg26227935 | 18 | 77,682,412 | intergenic | 3.13×10−7 | 6.91×10−3 | ↑ | |
cg19729949 | 5 | 142,514,108 | intergenic | 4.11×10−7 | 8.66×10−3 | ↑ | |
cg01869224 | 12 | 53,356,063 | intergenic | 4.79×10−7 | 9.13×10−3 | ↑ | |
cg05929056 | 21 | 43,274,690 | intergenic | 4.81×10−7 | 9.13×10−3 | ↑ | |
cg12538597 | 11 | 85,906,334 | intergenic | 5.13×10−7 | 9.13×10−3 | ↓ | |
cg20660860 | 2 | 122,095,855 | exons | 5.27×10−7 | 9.13×10−3 | CLASP1 | ↑ |
cg24663683 | 5 | 39,721,720 | intergenic | 5.26×10−7 | 9.13×10−3 | ↓ | |
cg09537031 | 8 | 19,171,706 | intergenic | 5.87×10−7 | 9.13×10−3 | ↑ | |
cg09828625 | 20 | 23,331,259 | promoters | 5.97×10−7 | 9.13×10−3 | NXT1 | ↑ |
cg08866589 | 5 | 141,303,260 | promoters | 6.02×10−7 | 9.13×10−3 | KIAA0141 | ↑ |
cg20208633 | 4 | 55,405,888 | intergenic | 6.19×10−7 | 9.13×10−3 | ↑ | |
cg07252851 | 5 | 74,063,056 | promoters | 6.55×10−7 | 9.29×10−3 | GFM2 | ↓ |
cg10690677 | 1 | 87,019,175 | introns | 6.73×10−7 | 9.29×10−3 | CLCA4 | ↓ |
cg12550816 | 19 | 47,163,979 | promoters | 7.07×10−7 | 9.46×10−3 | DACT3-AS1 | ↓ |
cg06159435 | 11 | 118,966,351 | promoters | 7.31×10−7 | 9.46×10−3 | H2AFX | ↓ |
cg13838599 | 9 | 128,989,097 | intergenic | 7.49×10−7 | 9.46×10−3 | ↑ | |
cg06459913 | 16 | 11,361,823 | introns | 7.93×10−7 | 9.59×10−3 | RMI2 | ↑ |
cg18803079 | 1 | 64,014,643 | promoters | 8.03×10−7 | 9.59×10−3 | EFCAB7 | ↓ |
cg14559409 | 10 | 65,930,703 | intergenic | 8.87×10−7 | 1.03×10−2 | ↓ | |
cg21962918 | 5 | 134,094,454 | intergenic | 1.00×10−6 | 1.11×10−2 | ↓ | |
cg02738677 | 3 | 133,265,129 | intergenic | 1.01×10−6 | 1.11×10−2 | ↓ | |
cg10269358 | 19 | 17,728,585 | exons | 1.03×10−6 | 1.11×10−2 | UNC13A | ↑ |
cg22331096 | 8 | 128,749,328 | introns | 1.16×10−6 | 1.21×10−2 | MYC | ↓ |
cg01778384 | 13 | 27,236,961 | introns | 1.20×10−6 | 1.21×10−2 | WASF3 | ↑ |
cg02746684 | 3 | 197,347,276 | introns | 1.23×10−6 | 1.21×10−2 | LOC220729 | ↑ |
cg08450091 | 3 | 82,857,215 | intergenic | 1.24×10−6 | 1.21×10−2 | ↓ | |
cg04005938 | 7 | 148,334,417 | intergenic | 1.27×10−6 | 1.21×10−2 | ↓ | |
cg27618483 | 2 | 155,433,424 | intergenic | 1.31×10−6 | 1.21×10−2 | ↓ | |
cg17095167 | 13 | 21,833,918 | intergenic | 1.31×10−6 | 1.21×10−2 | ↓ | |
cg01757206 | 17 | 7,183,913 | intergenic | 1.46×10−6 | 1.32×10−2 | SLC2A4 | ↓ |
cg26342398 | 1 | 85,156,326 | promoters | 1.61×10−6 | 1.42×10−2 | SSX2IP | ↓ |
The nearest annotated gene within ±5kb of the CpG probe
↑ indicates hypervariable (increased variability in subjects with higher neuropathological burden as compared to those with lower burden), and ↓ indicates hypovariable (decreased variability in subjects with higher neuropathological burden as compared to those with lower burden).